Cost-Effectiveness of Screening, Surveillance, and Endoscopic Eradication Therapies for Managing the Burden of Esophageal Adenocarcinoma

Gastrointest Endosc Clin N Am. 2021 Jan;31(1):77-90. doi: 10.1016/j.giec.2020.08.005. Epub 2020 Oct 26.

Abstract

The authors conducted a review of the literature of cost-effectiveness analyses regarding management of Barrett's esophagus, including screening, surveillance, and treatment strategies. Because of the presence of multiple systematic reviews on this topic, they chose to focus on more recent economic analyses, with an emphasis on comparative modeling because these analyses have been demonstrated to achieve greater validity and impact when there are multiple competing strategies that are clinically reasonable to pursue. The authors identified areas of consensus across studies regarding management strategies and also areas that require additional empirical data.

Keywords: Cost-benefit analysis; Costs and analysis; Health care costs; Systematic review.

Publication types

  • Systematic Review

MeSH terms

  • Adenocarcinoma / diagnosis
  • Adenocarcinoma / economics*
  • Adenocarcinoma / therapy
  • Aged
  • Barrett Esophagus / diagnosis
  • Barrett Esophagus / economics*
  • Barrett Esophagus / therapy
  • Cost-Benefit Analysis
  • Early Detection of Cancer / economics*
  • Early Detection of Cancer / methods
  • Esophageal Neoplasms / diagnosis
  • Esophageal Neoplasms / economics*
  • Esophageal Neoplasms / therapy
  • Esophagoscopy / economics*
  • Esophagoscopy / methods
  • Female
  • Humans
  • Male
  • Middle Aged
  • Precancerous Conditions / diagnosis
  • Precancerous Conditions / economics*
  • Precancerous Conditions / therapy
  • Quality-Adjusted Life Years

Supplementary concepts

  • Adenocarcinoma Of Esophagus